The mesenteric hemodynamic response to circulatory shock: An overview

Shock

Volumn 15, Issue 5, 2001, Pages 329-343

  Reilly, Patrick M ^a   Wilkins, Kirsten Bass ^b   Fuh, Katherine C ^e   Haglund, Ulf ^c   Bulkley, Gregory B ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e NONE

Author keywords

Acalculous cholecystitis; Free radicals; Hemorrhage; Ischemic colitis; Ischemic hepatitis; Ischemic pancreatitis; Nonocclusive mesenteric ischemia; Renin angiotensin axis; Sepsis; Splanchnic vasoconstriction; Tamponade

Indexed keywords

ANIMAL; HUMAN; PATHOPHYSIOLOGY; REVIEW; SHOCK; SPLANCHNIC BLOOD FLOW;

ANIMALS; HUMANS; SHOCK; SPLANCHNIC CIRCULATION;

EID: 0035344181     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200115050-00001     Document Type: Review

References (112)

1. Cannon WB: Bodily changes in pain, hunger, fear and rage: an account of recent researches into the function of emotional excitement. New York: D. Appleton & Co., 1920, pp 1-311.
2. Fine J: The intestinal circulation in shock. Gastroenterology 52:454-458, 1967.
3. Bernard C: Lecons de Physiologie Experimentale Appliquee a la Medicine. Paris: Baillies,et Fils, 1856, pp 406-409.
4. Haglund U: Systemic mediators released from the gut in critical illness. Crit Care Med 21:S15-S18, 1993.
5. Folkow B: Regional adjustments of intestinal blood flow. Gastroenterology 52:423-432, 1967.
6. Guyton AC: Muscle blood flow during exercise; cerebral, splanchnic and skin blood flows. In Guyton AC (ed): Textbook of Medical Physiology. Philadelphia: W.B. Saunders Company, 1981, pp 344-356.
7. Lundgren O, Haglund U: The pathophysiology of the intestinal countercurrent exchanger. Life Sci 23:1411-1422, 1978.
8. Haglund U, Hulten L, Ahren C, Lundgren O: Mucosal lesions in the human small intestine in shock. Gut 16:979-984, 1975.
9. Redfors S, Hallback DA, Haglund U, Jodal M, Lundgren O: Blood flow distribution, villous tissue osmolality and fluid and electrolyte transport in the cat small intestine during regional hypotension. Acta Physiol Scand 121:193-209, 1984.
10. Kvietys PR: Microcirculation of the large intestine. In Mortillaro NA (ed): The Physiology and Pharmacology of the Microcirculation. Orlando, FL: Academic Press, 1984, pp 77-94.
11. Lautt WW: Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 249:G549-G556, 1985.
12. 86Rb extraction during arterial hypoxia. Am J Physiol 234:E248-E251, 1978.
13. Jacobson ED, Pawlik WW: Adenosine regulation of mesenteric vasodilation. Gastroenterology 107:1168-1180, 1994.
14. Johnson PC: The myogenic response. In Bohr DF, Somlyo AT, Sparks HV (ed): Handbook of Physiology: Circulation Section 2, the Cardiovascular System. Baltimore, MD: Williams and Wilkins, 1980, pp 409-442.
15. Alemany CA, Oh W, Stonestreet BS: Effects of nitric oxide synthesis inhibition on mesenteric perfusion in young pigs. Am J Physiol 272:G612-G616, 1997.
16. Myers SI, Turnage RH, Hernandez R, Castenada A, Valentine RJ: Autoregulation of renal and splanchnic blood flow following infra-renal aortic clamping is mediated by nitric oxide and vasodilator prostanoids. J Cardiovasc Surg 37:97-103, 1996.
17. Granger HJ, Norris CP: Intrinsic regulation of intestinal oxygenation in the anesthetized dog. Am J Physiol 238:H836-H843, 1980.
18. Granger DN, Granger HJ: Systems analysis of intestinal hemodynamics and oxygenation. Am J Physiol 245:G786-G796, 1983.
19. Bulkley GB, Kvietys PR, Parks DA, Perry MA, Granger DN: Relationship of blood flow and oxygen consumption to ischemic injury in the canine small intestine. Gastroenterology 89:852-857, 1985.
20. Li KCP: Magnetic resonance angiography of the visceral arteries: techniques and current applications. Endoscopy 29:496-503, 1997.
21. McNeill JR, Wilcox WC, Pang CCY: Vasopressin and angiotensin: reciprocal mechanisms controlling mesenteric conductance. Am J Physiol 232:H260-H266, 1977.
22. McNeill JR, Stark RD, Greenway CV: Intestinal vasoconstriction after hemorrhage: roles of vasopressin and angiotensin. Am J Physiol 219:1342-1347, 1970.
23. Toung T, Reilly PM, Fuh KC, Ferris R, Bulkley GB: Mesenteric vasoconstriction in response to hemorrhagic shock. Shock 13:267-273, 2000.
24. Reilly PM, Toung TJ, Miyachi M, Schiller HJ, Bulkley GB: Hemodynamics of pancreatic ischemia in cardiogenic shock in pigs. Gastroenterology 113: 938-945, 1997.
25. Gershon MD, Erde SM: The nervous system of the gut. Gastroenterology 80:1571-1594, 1981.
26. Bailey RW, Brengman ML, Fuh KC, Hamilton SR, Herlong HF, Bulkley GB. Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation. Shock 14:451-459, 2000.
27. Pang PK, Tenner TE, Jr., Yee JA, Yang M, Janssen HF: Hypotensive action of parathyroid hormone preparations on rats and dogs. Proc Natl Acad Sci USA 77:675-678, 1980.
28. Pang PK, Yang MC, Kenny AD, Tenner TE, Jr.: Structure and vascular activity relationship of parathyroid hormone and some hypotensive peptides. Clin Exp Hypertens Part A Theory Pract 4:189-199, 1982.
29. Bailey RW, Bulkley GB, Hamilton SR, Morris JB, Haglund UH: Protection of the small intestine from nonocclusive mesenteric ischemia injury due to cardiogenic shock. Am J Surg 153:108-116, 1987.
30. Bailey RW, Bulkley GB, Hamilton SR, Morris JB, Smith GW: Pathogenesis of nonocclusive ischemic colitis. Ann Surg 203:590-599, 1986.
31. Bailey RW, Bulkley GB, Hamilton SR, Morris JB, Haglund U, Meilahn JE: The fundamental hemodynamic mechanism underlying gastric "stress ulceration" in cardiogenic shock. Ann Surg 205:597-611, 1987.
32. DiSalvo J, Britton S, Galvas P, Sanders TW: Effects of angiotensin I and angiotensin II on canine hepatic vascular resistance. Circ Res XXXII:85-92, 1973.
33. Bruneval P, Hinglais N, Alhenc-Gelas F, Tricottet V, Corvol P, Menard J, Camilleri JP, Bariety J: Angiotensin I converting enzyme in human intestine and kidney: ultrastructural immunohistochemical localization. Histochemistry 85:73-80, 1986.
34. Gunther S, Gimbrone MA, Jr., Alexander RW: Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery. Circ Res 47:278-286, 1980.
35. Said SI: Vasoactive peptides: state-of-the-art review. Hypertension 5(Pt 2):I17-I26,1983.
36. McNeill JR: Role of vasopressin and angiotensin in response of splanchnic resistance vessels to hemorrhage. In Hinshaw LB, Cox BG (ed): The fundamental mechanisms of shock. New York: Plenum Publishing, 1972, pp 127-144.
37. Arnolda L, McGrath BP, Johnston CI: Systemic and regional effects of vasopressin and angiotensin in acute left ventricular failure. Am J Physiol 260:H499-H506, 1991.
38. Bynum TE, Hanley HG: Effect of digitalis on estimated splanchnic blood flow. J Lab Clin Med 99:84-91, 1982.
39. Cernacek P, Stewart DJ: Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 161:562-567, 1989.
40. Vemulapalli S, Chiu PJS, Rivelli M, et al.: Tumor necrosis factor and hemorrhage produces elevation of plasma endothelin in rats. [Abstract] FASEB J 4:A456, 1990.
41. Zimmerman RS, Maymind M, Barbee RW: Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension 23:205-210, 1994.
42. Johnson RJ, Fink GD, Galligan JJ: Mechanisms of endothelin-induced vasoconstriction in isolated guinea pig mesentery. J Pharmacol Exp Ther 289: 762-767, 1999.
43. Jarrar D, Wang P, Cioffi WG, Bland KI, Chaudry IH: Mechanisms of the salutary effects of dehydroepiandrosterone after trauma-hemorrhage: direct or indirect effects on cardiac and hepatocellular functions'? Arch Surg 135:416-419, 2000.
44. Otter D, Austin C: Effects of 17β-oestradiol on rat isolated coronary and mesenteric artery tone: involvement of nitric oxide. J Pharm Pharmacol 50: 531-538, 1998.
45. Vacca G, Battaglia A, Grossini E, Mary DASG, Molinari C, Surico N: The effect of 17β-oestradiol on regional blood flow in anaesthetized pigs. J Physiol 514:875-884, 1999.
46. Banks RO, Gallavan RH, Jr., Zinner MJ, Bulkley GB, Harper SL, Granger DN, Jacobson ED: Vasoactive agents in control of the mesenteric circulation. Fed Proc 44:2743-2749, 1985.
47. Holliger C, Radzyner M, Knoblauch M: Effects of glucagon, vasoactive intestinal peptide, and vasopressin on villous microcirculation and superior mesenteric artery blood flow of the rat. Gastroenterology 85:1036-1043, 1983.
48. Granger DN, Richardson PD, Kvietys PR, Mortillaro NA: Intestinal blood flow. Gastroenterology 78:837-863, 1980.
49. Rothe CF: Reflex control of veins and vascular capacitance. Physiol Rev 63:1281-1342, 1983.
50. Arvidsson D, Rasmussen I, Almqvist P, Niklasson F, Haglund U: Splanchnic oxygen consumption in septic and hemorrhagic shock. Surgery 109:190-197, 1991.
51. Dahn MS, Lange P, Lobdell K, Hans B, Jacobs LA, Mitchell RA: Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 101:69-80, 1987.
52. Fink MP: Systemic and splanchnic hemodynamic derangements in the sepsis syndrome. In Marston A, Bulkley GB, Fiddian-Green RG, Haglund UH (ed): Splanchnic Ischemia and Multiple Organ Failure. London: Edward Arnold, 1989, pp 101-106.
53. Arvidsson D, Almquist P, Haglund U: Effects of positive-end expiratory pressure on splanchnic circulation and function in experimental peritonitis. Arch Surg 126:631-636, 1991.
54. Jacobson ED: Are adrenergic overactivity and splanchnic vasoconstriction the prime pathophysiological events in shock? In Hinshaw LB, Cox BG (ed): Advances in Experimental Medicine and Biology. New York: Plenum Press, 1971, pp 109-112.
55. Falk A, Kaijser B, Myrvold HE, Haglund U: Intestinal vascular and central hemodynamic responses in the cat following i.v. infusion of live E. coli bacteria. Circ Shock 7:239-250, 1980.
56. Ujhelyi MR, Miller AW, Raibon S, Corley J, Robinson VJB, Sims JJ, Tonnessen T, Burke G, Ilebekk A, Rutlen DL: Endotoxemia alters splanchnic capacitance. Shock 14:68-72, 2000.
57. Dal Nogare AR: Septic shock. Am J Med Sci 302:50-65, 1991.
58. Hsueh W, Gonzalez-Crussi F, Arroyave JL: Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1:403-405, 1987.
59. G-nitro-L-arginine methyl ester on testicular blood flow and serum steroid hormones during sepsis. Shock 9:416-421, 1998.
60. Ornan DA, Chaudry IH, Wang P: The dissociation between up-regulated endothelins and hemodynamic responses during polymicrobial sepsis. Biochim Biophys Acta 1501:211-218, 2000.
61. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29:1469-1477, 1997.
62. Law WR, Ferguson JL: Naloxone alters organ perfusion during endotoxin shock in conscious rats. Am J Physiol 255:H1106-H1113, 1988.
63. Salerno TA, Milne B, Jhamandas KH: Hemodynamic effects of naloxone in hemorrhagic shock in pigs. Surg Gynecol Obstet 152:773-776, 1981.
64. Motew SJ, Mourelatos MG, Miller RN, Ferguson JL, Law WR: Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats. Shock 7:439-446, 1997.
65. Motew SJ, Sam AD, II, Mourelatos MG, Sharma AC, Alden KJ, Ferguson JL, Law WR: Adenosine receptor antagonism affects regional resting vascular resistance during rat peritoneal sepsis. J Surg Res 80:326-332, 1998.
66. Salzman AL: Nitric oxide in the gut. New Horizons 3:352-364, 1995.
67. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
68. Hauser GJ, Dayao EK, Wasserloos K, Pitt BR, Wong HR: HSP induction inhibits iNOS mRNA expression and attenuates hypotension in endotoxin-challenged rats. Am J Physiol 271:H2529-H2535, 1996.
69. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P: Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28:34-39, 1994.
70. Kiehl MG, Ostermann H, Meyer J, Kienast J: Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med 23:561-566, 1997.
71. Kilbourn RG, Szabo C, Traber DL: Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7:235-246, 1997.
72. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC: Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96:4820-4825, 1999.
73. Taylor DE, Kantrow SP, Piantadosi CA: Mitochondrial respiration after sepsis and prolonged hypoxia. Am J Physiol 275:L139-L144, 1998.
74. Bailey RW, Bulkley GB, Hamilton SR, Herlong HF. Protection of the liver from ischemic injury due to cardiogenic shock. [Abstract] Gastroenterology 90:1708, 1986.
75. Yamakawa Y, Takano M, Patel M, Tien N, Takada T, Bulkley GB: Interaction of PAF, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. Ann Surg 231:387-398, 2000.
76. Mayumi T, Chan CK, Clemens MG, Bulkley GB: Zonal heterogeneity of hepatic injury following shock/resuscitation: relationship of xanthine oxidase activity to localization of neutrophil accumulation and central lobular necrosis. Shock 5:324-332, 1996.
77. Reilly PM, Toung TJ, Miyachi M, Schiller HJ, Bulkley GB: The fundamental hemodynamic mechanism of gallbladder ischemia during cardiogenic shock. [Abstract] Gastroenterology 108(4):A316, 1995.
78. Kvietys PR, Granger DN: Relation between intestinal blood flow and oxygen uptake. Am J Physiol 242:G202-G208, 1982.
79. Haglund U, Abe T, Ahren C, Braide I, Lundgren O: The intestinal mucosal lesions in shock: I. Studies on the pathogenesis. Eur Surg Res 8:435-447, 1976.
80. Piper HM: Mechanism of myocardial injury during acute reperfusion. News Physiol Sci 12:53-54, 1997.
81. Levine RL: Ischemia: from acidosis to oxidation. FASEB J 7:1242-1246, 1993.
82. Bulkley GB, Haglund UH, Morris JB: Mesenteric blood flow and the pathophysiology of intestinal ischemia. In Bergan JJ, Yao JST (ed): Vascular Surgical Emergencies. Orlando, FL: Grune & Stratton, 1987, pp 25-41.
83. Bounous G: Pancreatic proteases and oxygen-derived free radicals in acute ischemic enteropathy. Surgery 99:92-94, 1986.
84. Mitsuoka H, Kistler EB, Schmid-Schönbein GW: Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes. Proc Natl Acad Sci USA 97:1772-1777, 2000.
85. Miyachi M, Bulkley GB. Quantitative in situ histochemical localization of the activation by ischemia of xanthine oxidoreductase (XOR) from the dehydrogenase (XD) to the oxidase (XO) form within the villus tip enterocyte of the rat jejunum. [Abstract] Gastroenterology 100:A231, 1991.
86. Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. Gastroenterology 81:22-29, 1981.
87. Ichikawa H, Wolf RE, Aw TY, Ohno N, Coe L, Granger DN, Yoshikawa T, Alexander JS: Exogenous xanthine promotes neutrophil adherence to cultured endothelial cells. Am J Physiol 273:G342-G347, 1997.
88. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN: Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 253:H699-H703, 1987.
89. Takano M, Sheikh E, Hopkins E, Bulkley GB. Post-transcriptional P-selectin expression by endothelial cells in vitro is dependent upon enzymatically generated reactive oxygen metabolites (ROMS). [Abstract] Gastroenterology 116:A936-A937, 1999.
90. Ratych RE, Chuknyiska RS, Bulkley GB: The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells. Surgery 102:122-131, 1987.
91. Ward PA, Warren JS, Johnson KJ: Oxygen radicals, inflammation, and tissue injury. Free Radic Biol Med 5:403-408, 1988.
92. Bulkley GB: Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function. Lancet 344:934-936, 1994.
93. Klein AS, Wang D, Takao S, Kondo S, and Bulkley GB. Oxidant-mediated phagocytic killing by the hepatic reticuloendothelial system (forthcoming).
94. Kera Y, Ohbora Y, Komura S: The metabolism of acetaldehyde and not acetaldehyde itself is responsible for in vivo ethanol-induced lipid peroxidation in rats. Biochem Pharmacol 37:3633-3638, 1988.
95. Haglind E, Wang D, Klein AS: Hepatic reticuloendothelial system dysfunction after intestinal ischemia-reperfusion. Shock 5:72-75, 1996.
96. Silen W, Merhav A, Simson JNL: The pathophysiology of stress ulcer disease. World J Surg 5:165-174, 1981.
97. Mersereau WA, Hinchey EJ: Effect of gastric acidity on gastric ulceration induced by hemorrhage in the rat, utilizing a gastric chamber technique. Gastroenterology 64:1130-1135, 1973.
98. Kistler EB, Lefer AM, Hugli TE, Schmid-Schonbein GW: Plasma activation during splanchnic arterial occlusion shock. Shock 14:30-34, 2000.
99. Bounous G, Menard D, De Medicis E: Role of pancreatic proteases in the pathogenesis of ischemic enteropathy. Gastroenterology 73:102-108, 1977.
100. Amano H, Bulkley GB, Gorey T, Hamilton SR, Horn SD, Zuidema GD: Role of microvascular patency in the recovery of small intestine from ischemic injury. Surg Forum XXXI:157-159, 1980.
101. Bulkley GB, Zuidema GD, Hamilton SR, O'Mara CS, Klacsmann PG, Horn SD: Intraoperative determination of small intestinal viability following ischemic injury: a prospective, controlled trial of two adjuvant methods (Doppler and fluorescein) compared with standard clinical judgment. Ann Surg 193: 628-637, 1981.
102. Zimmerman JE, Knaus WA, Sun X, Wagner DP: Severity stratification and outcome prediction for multisystem organ failure and dysfunction. World J Surg 20:401-405, 1996.
103. Cerra FB: The hypermetabolism organ failure complex. World J Surg 11:173-181, 1987.
104. Bone RC: Toward an epidemiology and natural history of SIRS. J Am Med Assoc 268:3452-3455, 1992.
105. Meakins JL, Marshall JC: The gut as the motor of multiple system organ failure. In Marston A, Bulkley GB, Fiddian-Green RG, Haglund UH (ed): Splanchnic Ischemia and Multiple Organ Failure. London: Edward Arnold, 1989, pp 339-348.
106. Biffl WL, Moore EE: Splanchnic ischaemia/reperfusion and multiple organ failure. Br J Anaesth 77:59-70, 1996.
107. Cerra FB, Shronts EP, Konstantinides NN, Thoele S, Konstantinides FN, Teasley K, Lysne J: Enteral feeding in sepsis: a prospective randomized double-blind trial. Surgery 98:632-639, 1985.
108. McAnena OJ, Moore FA, Moore EE, Jones TN, Parsons P: Selective uptake of glutamine in the gastrointestinal tract: confirmation in a human study. Brit J Surg 78:480-482, 1991.
109. Terregino CA, Lopez BL, Karras DJ, Killian AJ, Arnold GK: Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death? Ann Emerg Med 35:26-34, 2000.
110. Tate RM, Repine JE: Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 128:552-559, 1983.
111. Poole JW, Sammartano RJ, Boley SJ: The use of tonometry in the early diagnosis of mesenteric ischemia. Curr Surg 44:21-24, 1987.
112. Lundgren O: Physiology of the intestinal circulation. In Marston A, Bulkley GB, Fiddian-Green RG, Haglund UH (ed): Splanchnic Ischemia and Multiple Organ Failure. London: Edward Arnold, 1989, pp 29-40.